Edition:
United States

ALS Ltd (ALQ.AX)

ALQ.AX on Australia Stock Exchange

7.83AUD
25 Sep 2017
Change (% chg)

$0.03 (+0.38%)
Prev Close
$7.80
Open
$7.77
Day's High
$7.94
Day's Low
$7.61
Volume
1,364,381
Avg. Vol
2,022,715
52-wk High
$8.50
52-wk Low
$5.59

Summary

Name Age Since Current Position

Bruce Phillips

62 2016 Independent Non-Executive Chairman of the Board

Raj Naran

2017 Chief Executive Officer, Managing Director, Director

Richard Stephens

2010 Chief Financial Officer

Kristen Walsh

Group General Manager - Industrial Division

Tim Mullen

2007 Company Secretary

Tonianne Dwyer

54 2016 Non-Executive Director

Melvyn Bridges

67 2009 Independent Non-Executive Director

John Mulcahy

67 2012 Independent Non-Executive Director

Grant Murdoch

65 2011 Independent Non-Executive Director

Charles Sartain

56 2015 Independent Non-Executive Director

Biographies

Name Description

Bruce Phillips

Mr. Bruce John Phillips has been appointed as Independent Non-Executive Chairman of the Board of the Company effective July 26, 2016. Bruce Phillips was appointed a non-executive director of the Company on 1 August 2015 and became Chairman on 26 July 2016 following the 2016 Annual General Meeting. Bruce is a qualified geophysicist with more than 35 years of technical, financial and managerial experience in the energy sector. He founded Australian Worldwide Exploration Limited (ASX: AWE) in 1997 and was its Managing Director until his retirement in 2007. He re-joined as a non-executive director in 2009 and is currently its Chairman. He was previously Chairman of Platinum Capital Limited (October 2009 – June 2015) and a non-executive director of AGL Energy Limited (August 2007 – September 2016) and Sunshine Gas Limited. He is a member of the People Committee.

Raj Naran

Mr. Raj Naran has been appointed as Chief Executive Officer, Managing Director, Director of ALS Ltd, effective July 20, 2017. Raj is an experienced global executive in the Testing, Inspection & Certification (TIC) Industry. He holds a Bachelor of Science majoring in Chemistry and a Bachelor of Arts majoring in Mathematics as well as management training qualifications. Upon graduating in 1984, he commenced employment with several global corporations including Environmental Resources Management (ERM), a global consulting business. Through his career, he undertook field based work before progressing to his first laboratory management role in Houston. When ERM sold its’ laboratory operations to Core Laboratories, Inc in the US in the early 1990s, Mr Naran transferred with it. Core Laboratories is a service provider of core and fluid analysis in the petroleum and resources industries. After seven years as Laboratory Manager in which he had both laboratory and business development responsibilities, Mr Naran departed in 1999 to commence his own business known as e-Lab Analytical, Inc. Headquartered in Houston, the company built a presence in North America, South America, and Australia. After eight years of growing the business, e Lab was acquired by ALS in 2007. Mr Naran was retained after the acquisition and given the opportunity to run ALS’ Environmental Division for North America and Europe based in Houston, Texas. He was later appointed in 2012 to lead the Global Life Sciences Division of ALS growing the business significantly through both organic and M&A initiatives that has delivered 75% growth in the division over the five-year period since 2012. Strategy during this time focused on building the global Food and Pharmaceutical, Consumer Products and Water businesses and expanding the global footprint especially in North and South America, Asia and Europe.

Richard Stephens

Mr. Richard Stephens, B Com, CA, is Chief Financial Officer of ALS Ltd. He is responsible for the overall financial management of the Group, including treasury and taxation.

Kristen Walsh

Ms. Kristen Walsh, MBA, B Sc (Hons) (Civil and Environmental Engineering), is Group General Manager of Industrial Division of ALS Ltd. She is responsible for the strategic management of the Industrial Division. She was previously Chief Operating Officer of PearlStreet Limited prior to ALS’ acquisition of the company in 2009.

Tim Mullen

Mr. Tim Mullen, B Bus (Accounting), M Com Law, FCPA, FCIS, FCLA, is Company Secretary of ALS Ltd., since February 27, 2007. He is responsible for corporate governance of the Group, incorporating company secretarial, legal management and investor relations.

Tonianne Dwyer

Ms. Tonianne A. Dwyer serves as Non-Executive Director of the Company. Tonianne Dwyer was appointed a non-executive director of the Company on 1 July 2016. She has significant experience as a company director and executive working in finance, corporate strategy and mergers and acquisitions across a variety of sectors and international markets. She is an internationally experienced independent company director, having had a 25-year executive career in investment banking during which she held roles with Hambros Bank Limited and Societe General in the UK and Europe. Tonianne currently holds non-executive directorships on ASXlisted companies OZ Minerals Limited (appointed March 2017), Metcash Limited (appointed June 2014), DEXUS Property Group and DEXUS Wholesale Property Fund (appointed August 2011). She is also a non-executive director of Queensland Treasury Corporation and is Deputy Chancellor of the Senate of the University of Queensland. She was previously a non-executive director of Cardno Limited ( June 2012 - January 2016). She is a member of the People and Sustainability Committees.

Melvyn Bridges

Dr. Melvyn (Mel) John Bridges, B AppSc, FAICD, is an Independent Non-Executive Director of ALS Ltd., since September 29, 2009. Mel Bridges was appointed a non-executive director of the Company in 2009. He has over 35 years’ experience founding and building international lifescience, diagnostic and medical device companies and commercialising a wide range of Australian technology. He is Chairman of Anatara Lifesciences Limited (appointed October 2014) and Oventus Medical Limited (appointed October 2015). Mel was previously Chairman of Alchemia Limited (September 2003 – July 2013) and a non-executive director of Tissue Therapies Limited (March 2009 – November 2015), ImpediMed Limited (September 1999 – November 2013) and Benitec Limited (October 2007 - June 2014). He is a member of the Audit and Risk and Sustainability Committees.

John Mulcahy

Dr. John Francis Mulcahy, Ph.D., BE (Civil Eng) (Hons), FIE Aust, has been Independent Non-Executive Director of ALS Ltd., since February 1, 2012. John Mulcahy was appointed a non-executive director of the Company in 2012. He is Chairman of Mirvac Group Limited (appointed November 2009 and Chair September 2013) and Orix Australia Corporation Limited, an unlisted public company (appointed March 2016), and Deputy Chairman of GWA Group Limited (appointed November 2010). John was previously a director and Chairman of Coffey International Limited (September 2009 – January 2016). He is a former Guardian of the Future Fund of Australia and former Managing Director and Chief Executive Officer of Suncorp-Metway Limited. Prior to Suncorp, John held a number of senior executive roles at the Commonwealth Bank and Lend Lease Corporation. He is Chairman of the People Committee.

Grant Murdoch

Mr. Grant Bruce Murdoch, M COM (Hons), FAICD, FCA is an Independent Non-Executive Director of ALS Ltd., since September 1, 2011. Grant Murdoch was appointed a non-executive director of the Company in 2011. He was formerly a Partner of Ernst & Young and Divisional Director of Ernst & Young Transaction Advisory Services Limited in Queensland. He has more than 37 years of chartered accountancy experience, specialising in mergers, acquisitions, takeovers, corporate restructures and share issues. Grant is a non-executive director of Redbubble Limited (appointed February 2016), OFX Group Limited (formerly OzForex Limited) (appointed October 2013) and is a director of Queensland Investment Corporation (QIC) and UQ Holdings Ltd. He is a senator of the University of Queensland, an Adjunct Professor at the University of Queensland Business School and a member on the Queensland Council of the Australian Institute of Company Directors. He was previously a non-executive director of Cardno Limited ( January 2013 – November 2015). He is Chairman of the Audit and Risk Committee.

Charles Sartain

Mr. Charles Sartain serves as Independent Non-Executive Director of the Company. Charlie Sartain was appointed a non-executive director of the Company on 1 February 2015. He spent more than 30 years with MIM Holdings and then Xstrata after it acquired MIM. He led Xstrata’s global copper business as Chief Executive of Xstrata Copper for nine years from 2004 and prior to that held senior executive positions with the company in Latin America and Australia. Charlie is currently a non-executive director of Goldcorp Inc. (appointed January 2017), Austin Engineering Limited (appointed April 2015), Chairman of the Advisory Board of the Sustainable Minerals Institute at the University of Queensland and a member of the UQ Senate. He is also a Board Member of Wesley Medical Research. Previously he was Chairman of the International Copper Association, a Member of the Department of Foreign Affairs and Trade’s Council on Australian Latin American Relations and a Director of Xstrata Schweiz Limited. He is Chairman of the Sustainability Committee and a member of the Audit and Risk Committee.

Basic Compensation

Name Fiscal Year Total

Bruce Phillips

275,645

Raj Naran

1,024,760

Richard Stephens

645,406

Kristen Walsh

604,830

Tim Mullen

--

Tonianne Dwyer

133,246

Melvyn Bridges

182,140

John Mulcahy

178,296

Grant Murdoch

190,807

Charles Sartain

182,296
As Of  30 Mar 2017